Results 41 to 50 of about 6,343 (174)

Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study

open access: yesNutrition in Clinical Practice, Volume 41, Issue 4, Page 1132-1143, August 2026.
Abstract Background The Crohn's Disease Exclusion Diet (CDED) offers a dietary means of inducing and maintaining remission for patients with Crohn's disease (CD). Descriptions of efficacy have emerged primarily from Israel, Europe, and Canada. Here, we offer real‐world experience, from a tertiary care center in the United States. Methods We conducted a
Mayah Greenfield   +5 more
wiley   +1 more source

Development of a 3D‐Printed Electrochemical Platform With Dual Working Electrodes for Mesalamine Detection

open access: yesAnalysis &Sensing, Volume 6, Issue 4, July 2026.
This work presents a fully 3D‐printed, low‐cost multiplexed electrochemical platform with dual working electrodes for mesalamine detection. Chemical/electrochemical activation enhances electrode performance, enabling sensitive and reproducible quantification in biological matrices.
Mariana A. de Jesus   +8 more
wiley   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2162-2170, July 2026.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine

open access: yesClinical Pharmacology: Advances and Applications, 2012
Kavinderjit Nanda, Alan C MossCenter for Inflammatory Bowel Disease, BIDMC/Harvard Medical School, Boston, MA, USAAbstract: Ulcerative colitis (UC) is a chronic inflammatory disease of the colon that typically manifests as diarrhea, abdominal pain, and ...
Nanda K, Moss AC
doaj  

Differential diagnosis problem of pulmonary changes in ulcerative colitis [PDF]

open access: yesVojnosanitetski Pregled, 2010
Introduction. Inflammatory intestinal diseases are often accompanied with extraintestinal and even pulmonary manifestations. The treatment of these intestinal diseases includes sulphasalazine and mesalazine, which may have undesirable allergic and other ...
Đurić Mirna   +3 more
doaj   +1 more source

The decline of 6‐thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2364-2376, July 2026.
Background Thiopurines are used to maintain remission in inflammatory bowel disease (IBD). These drugs are metabolized into 6‐thioguanine nucleotides (6‐TGN), associated with efficacy, and 6‐methylmercaptopurine ribonucleotides (6‐MMPR), associated with adverse drug reactions. Pregnancy has been linked to a shift in thiopurine metabolism, characterized
Dianne G. Bouwknegt   +13 more
wiley   +1 more source

Mesalazine‐Induced Myocarditis: A Challenging Diagnostic Journey

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
Cardiac MRI imaging showing patterns consistent with acute myocarditis. ABSTRACT Mesalazine‐induced myocarditis, though rare, should be suspected in patients presenting with acute chest pain and elevated cardiac biomarkers shortly after treatment initiation. Cardiac MRI plays a pivotal role in diagnosis. Prompt drug discontinuation often leads to rapid
Mohamed Zakaria Bouayed   +7 more
wiley   +1 more source

The Safety of Treating Women With Inflammatory Bowel Disease With Allopurinol and Low‐Dose Thiopurine During Pregnancy: A Single‐Center Experience

open access: yesJCC Plus, Volume 1, Issue 4, July 2026.
ABSTRACT Background Low‐dose thiopurine therapy in combination with allopurinol (LD‐THIO/ALLO) is a widely used treatment for inflammatory bowel disease (IBD). However, little is known about the effects of in utero exposure to this combination on pregnancy and birth outcomes.
Kavitha Sivananthan   +9 more
wiley   +1 more source

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine

open access: yesPatient Preference and Adherence, 2009
Daniel B Zandman, Mark A PeppercornHarvard Medical School, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Mesalamine and its derivatives are effective and well-tolerated therapies for ...
Daniel B Zandman, Mark A Peppercorn
doaj  

Impact of 5‐Aminosalicylic acid discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 1, Page 96-107, July 2026.
Abstract Objectives 5‐Aminosalicylic acid (5‐ASA) is recommended as a first‐line medication in mild to moderate ulcerative colitis (UC), but indications regarding its use in children with moderate to severe disease treated with biologics are lacking.
Giulia D'Arcangelo   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy